Rheumatoid arthritis

被引:33
|
作者
Diaz-Gonzalez, Federico [1 ,2 ,3 ]
Hernandez-Hernandeza, Maria V. [1 ]
机构
[1] Hosp Univ Canarias, Serv Reumatol, Tenerife, Spain
[2] Univ La Laguna, Dept Med Interna Dermatol & Psiquiatria, San Cristobal De La Lagun, Tenerife, Spain
[3] Univ La Laguna, Inst Univ Tecnol Biomed ITB, San Cristobal De La Lagun, Tenerife, Spain
来源
MEDICINA CLINICA | 2023年 / 161卷 / 12期
关键词
Rheumatoid arthritis; Etiopathogenesis; Treatment; Treat to target strategy; Disease activity; CITRULLINATED PEPTIDE ANTIBODIES; DISEASE-ACTIVITY SCORE; C-REACTIVE PROTEIN; CLASSIFICATION CRITERIA; CLINICAL-PRACTICE; AMERICAN-COLLEGE; DOUBLE-BLIND; ANTI-TNF; METHOTREXATE; MORTALITY;
D O I
10.1016/j.medcli.2023.07.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rheumatoid arthritis (RA) is a chronic inflammatory multisystemic disease of unknown etiology and autoimmune nature that predominantly affects peripheral joints in a symmetrical fashion. Although much progress has been made in understanding the pathophysiology of RA, its etiology remains unknown. Tumor necrosis factor (TNF)-a and interleukin (IL)-6 play the important roles in the pathogenesis and maintenance of inflammation in RA. The presence of anti-citrullinated peptide antibodies aids in the diagnosis in patients with undifferentiated polyarthritis and is associated with a more aggressive RA. The natural history of RA causes joint deformity and disability, as well as reduced life expectancy, both due to increased cardiovascular risk, pulmonary involvement, infections, iatrogenesis or tumors. Early diagnosis and the use of targeted drugs to induce early remission have improved the RA prognosis. (c) 2023 Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:533 / 542
页数:10
相关论文
共 50 条
  • [31] Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis
    O'Neil, Liam J.
    Hu, Pingzhao
    Liu, Qian
    Islam, Md. Mohaiminul
    Spicer, Victor
    Rech, Juergen
    Hueber, Axel
    Anaparti, Vidyanand
    Smolik, Irene
    El-Gabalawy, Hani S.
    Schett, Georg
    Wilkins, John A.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [32] Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis
    Nas, Kemal
    Karkucak, Murat
    Durmus, Bekir
    Karatay, Saliha
    Capkin, Erhan
    Kaya, Arzu
    Ucmak, Derya
    Akar, Zeynel Abidin
    Cevik, Remzi
    Kilic, Erkan
    Kilic, Gamze
    Ozgocmen, Salih
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2015, 18 (08) : 873 - 879
  • [33] Intensive treatment and treatment holiday of TNF-inhibitors in rheumatoid arthritis
    Tanaka, Yoshiya
    CURRENT OPINION IN RHEUMATOLOGY, 2012, 24 (03) : 319 - 326
  • [34] An evaluation of molecular and clinical remission in rheumatoid arthritis by assessing radiographic progression
    Mil, Annette H. M. van der Helm-van
    Knevel, Rachel
    Cavet, Guy
    Huizinga, Tom W. J.
    Haney, Douglas J.
    RHEUMATOLOGY, 2013, 52 (05) : 839 - 846
  • [35] The CAMERA (Computer-Assisted Management in Early Rheumatoid Arthritis) studies
    Jacobs, J. W. G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (04) : S39 - S43
  • [36] Rheumatoid arthritis
    Di Matteo, Andrea
    Bathon, Joan M.
    Emery, Paul
    LANCET, 2023, 402 (10416) : 2019 - 2033
  • [37] Prediction of response to methotrexate in rheumatoid arthritis
    Ling, Stephanie
    Bluett, James
    Barton, Anne
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (05) : 419 - 429
  • [38] Advances in the Medical Treatment of Rheumatoid Arthritis
    Tancer, Stephanie
    Wallace, Beth I.
    HAND CLINICS, 2025, 41 (01) : 11 - 23
  • [39] Insights Into the Concept of Rheumatoid Arthritis Flare
    Bozzalla-Cassione, Emanuele
    Grignaschi, Silvia
    Xoxi, Blerina
    Luvaro, Terenzj
    Greco, Maria Immacolata
    Mazzucchelli, Iolanda
    Bugatti, Serena
    Montecucco, Carlomaurizio
    Manzo, Antonio
    FRONTIERS IN MEDICINE, 2022, 9